Pasar al contenido principal

EPIGENETICA DEL PROCESO DE TRANSICION DE EPITELIO A MESENQUIMA Y SU REVERSION

BFU2017-85420-R

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos I+D+i Retos de Investigación
Año convocatoria 2017
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 11
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

TBL1 is required for the mesenchymal phenotype of transformed breast cancer cells

  • Rivero, Sabrina
  • Gómez-Marín, Elena
  • Guerrero-Martínez, José A.
  • García-Martínez, Jorge
  • Reyes, José C.
The epithelial-to-mesenchymal transition (EMT) and its reversion (MET) are related to tumor cell dissemination and migration, tumor circulating cell generation, cancer stem cells, chemoresistance, and metastasis formation. To identify chromatin and epigenetic factors possibly involved in the process of EMT, we compare the levels of expression of epigenetic genes in a transformed human breast epithelial cell line (HMEC-RAS) versus a stable clone of the same cell line expressing the EMT master regulator ZEB1 (HMEC-RAS-ZEB1). One of the factors strongly induced in the HMEC-RAS-ZEB1 cells was Transducin beta-like 1 (TBL1), a component of the NCoR complex, which has both corepressor and coactivator activities. We show that TBL1 interacts with ZEB1 and that both factors cooperate to repress the promoter of the epithelial gene E-cadherin (CDH1) and to autoactivate the ZEB1 promoter. Consistent with its central role, TBL1 is required for mesenchymal phenotypes of transformed breast epithelial and breast cancer cell lines of the claudin-low subtype. Importantly, a high expression of the TBL1 gene correlates with poor prognosis and increased proportion of metastasis in breast cancer patients, indicating that the level of TBL1 expression can be used as a prognostic marker., This work was funded by the Spanish Ministry of Economy and Competitiveness (BFU2014-53543-P and BFU2017-85420-R to J.C.R.), the Junta de Andalucía (BIO-321), and the European Union (FEDER). CABIMER is a Center partially funded by the Junta de Andalucía.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Overexpression of canonical prefoldin associates with the risk of mortality and metastasis in non-small cell lung cancer

  • Peñate, Xenia
  • Praena-Fernández, Juan Manuel
  • Romero Pareja, Pedro
  • Enguix-Riego, María del Valle
  • Payán-Bravo, Laura
  • Vieites, Begoña
  • Gómez Izquierdo, Lourdes
  • Jaen Olasolo, Javier
  • Rivin del Campo, Eleonor
  • Reyes, José C.
  • Chávez, Sebastián
  • López-Guerra, José Luis
Canonical prefoldin is a protein cochaperone composed of six different subunits (PFDN1 to 6). PFDN1 overexpression promotes epithelial–mesenchymal transition (EMT) and increases the growth of xenograft lung cancer (LC) cell lines. We investigated whether this putative involvement of canonical PFDN in LC translates into the clinic. First, the mRNA expression of 518 non-small cell LC (NSCLC) cases from The Cancer Genome Atlas (TCGA) database was evaluated. Patients with PFDN1 overexpression had lower overall survival (OS; 45 vs. 86 months; p = 0.034). We then assessed the impact of PFDN expression on outcome in 58 NSCLC patients with available tumor tissue samples. PFDN1, 3, and 5 overexpression were found in 38% (n = 22), 53% (n = 31), and 41% (n = 24) of tumor samples. PFDN1, 3, and 5 overexpression were significantly associated with lower OS, lower disease-free survival (DFS), and lower distant metastasis-free survival (DMFS) for PFDN1 and 3 with a trend for PFDN5. In multivariate analysis, PFDN5 retained significance for OS (hazard ratio (HR) 2.56; p = 0.007) and PFDN1 for DFS (HR 2.53; p = 0.010) and marginally for DMFS (HR 2.32; p = 0.053). Our results indicate that protein response markers, such as PFDN1, 3, and 5, may complement mRNA signatures and be useful for determining the most appropriate therapy for NSCLC patients., This work was co-funded by the Spanish Ministry of Economy and Competitiveness (BFU2017-85420-R to JCR and BFU2016-7772-C3-1-P to SC) and by the Andalusian Government (BIO-271) and the University of Seville (US-1256285 to SC) in cooperation with the European Regional Development Fund., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

TGFβ promotes widespread enhancer chromatin opening and operates on genomic regulatory domains

  • Guerrero-Martínez, José A.
  • Ceballos-Chávez, María
  • Koehler, Florian
  • Peiró, Sandra
  • Reyes, José C.
The Transforming Growth Factor-β (TGFβ) signaling pathway controls transcription by regulating enhancer activity. How TGFβ-regulated enhancers are selected and what chromatin changes are associated with TGFβ-dependent enhancers regulation are still unclear. Here we report that TGFβ treatment triggers fast and widespread increase in chromatin accessibility in about 80% of the enhancers of normal mouse mammary epithelial-gland cells, irrespective of whether they are activated, repressed or not regulated by TGFβ. This enhancer opening depends on both the canonical and non-canonical TGFβ pathways. Most TGFβ-regulated genes are located around enhancers regulated in the same way, often creating domains of several co-regulated genes that we term TGFβ regulatory domains (TRD). CRISPR-mediated inactivation of enhancers within TRDs impairs TGFβ-dependent regulation of all co-regulated genes, demonstrating that enhancer targeting is more promiscuous than previously anticipated. The area of TRD influence is restricted by topologically associating domains (TADs) borders, causing a bias towards co-regulation within TADs., This work was funded by the Spanish Ministry of Economy and Competitiveness (BFU2014-53543-P and BFU2017-85420-R to J.C. Reyes), the Junta de Andalucía (BIO-321), “Fundación Vencer El Cancer” (VEC) and the European Union (FEDER). CABIMER is a Center partially funded by the Junta de Andalucía. S.P was supported by the FERO Foundation, La Caixa Foundation (LCF/PR/PR12/51070001) and Cellex Foundation., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Contribución de congreso (ConferenceOutput)

Obesity-Induced Astrogliosis Is Regulated by the Diabesity Factor HMG20A

  • Mellado-Gil, José Manuel
  • Fuente-Martín, Esther
  • Lorenzo, Petra Isabel
  • Cobo-Vuilleumier, Nadia
  • Guerrero-Martínez, José A.
  • Romero-Zerbo, Silvana Y.
  • Franco, Jaime M.
  • Pérez-Cabello, Jesús Ángel
  • Álvarez-Dolado, Manuel
  • Pozo, David
  • Bermúdez-Silva, Francisco Javier
  • Reyes, José C.
  • Gauthier, Benoit R.
Resumen del trabajo presentado en el American Diabetes Association Meeting (2020), celebrado online del 12 al 16 de junio de 2020, It is well established that systemic glucose homeostasis is imparted by an intricate cross-talk among several organs including the central nervous system (CNS) and pancreatic islets. In analogy to islet beta cells, hypothalamic astrocytes are glucose sensors that facilitate the CNS response to changing metabolic environment. Therefore, astrocytes and beta cells may share a common genetic signature implicated in coupling glucose metabolism to cellular output. We recently demonstrated that the diabesity factor HMG20A is essential for beta-cell functional maturity and adaptation to physiological stress (obesity, type 2 diabetes and pregnancy). As this chromatin remodelling factor also dictates CNS development, we sought to determine whether HMG20A is expressed in astrocytes and whether it potentiates astrocyte function in response to environmental cues. We found that HMG20A is expressed in hypothalamic astrocytes and is upregulated in diet-induced obesity and glucose-intolerant mice, correlating with increased transcript levels of GFAP and IL-1β, indicative of reactive astrocytes (astrogliosis). High glucose, but not lipids, transiently decreased HMG20A expression in isolated mouse primary astrocytes. HMG20A silencing in astrocytes resulted in repression of pro-inflammatory as well as lipid and glucose metabolism genes. These pathways are up-regulated in activated astrocytes (astrogliosis) to resolve stress conditions. As such astrocyte depleted of HMG20A were more susceptible to cell death. Furthermore, motor neuron viability in astrocyte conditioned media was significantly hindered after HMG20A depletion in astrocytes. We posit that HMG20A is involved in the astrocyte polarization state. Under physiological pressure such as obesity, HMG20A expression may be transiently decreased by high glucose but long-term it is increased to induce astrogliosis in an attempt to preserve the neuronal network and glucose homeostasis., ISCIII (PI13/00593 to B.R.G.), (PI13/00309 to F.J.B-S.); Ministerio de Economia y Competidividad/Fondos FEDER (PI10/00871, PI13/00593, BFU2017-83588-P to B.R.G.); BFU2017-85420-R (to J.C.R.); (JCI-2012-12491, IJCI-2015-26238 to E.F-M.); Consejería de Salud Junta de Andalucía (PI-0006-2016 to E.F-M.), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Tesis de maestría (MasterThesis)

Computational analysis of TGF-β-mediated post-transcriptional regulation, Estudio genómico de la regulación postranscripcional mediada por TGFbeta

  • Sánchez-Escabias, Elena
Bioinformatic approaches have increased their relevance in the latest years, being computational analysis a crucial tool for genomics and transcriptomics. To better understand how transforming growth factor beta (TGF-β) influence post-transcriptional regulation and RNA splicing we performed a wide computational analysis comparing RNA sequencing (RNA-seq) and Chromatinenriched RNA-seq (ChRNA-seq) data provided by Dr. Reyes’ group. TGF-β provoked changes in both nuclear and cytoplasmatic post-transcriptional regulation being the cytoplasmatic component crucial to gene expression direction. Thus, a positive (or negative) change in cytoplasmatic posttranscriptional regulation affect gene expression in the cell. In order to investigate splicing efficiency at the whole gene level we created the Splicing Index of the Gene (SIG) parameter. Genes with high SIG were characterized by high exon signal, a few reads in intronic regions and were less expressed in the nucleus. On the contrary, genes with low SIG were more expressed and had similar signal in exonic regions than in the intronic. Differences of SIG between genes were related to gene length and splicing site sequences. We observed a rough positive correlation between splicing efficiency and gene length, so we developed a model based on co-transcriptional nature of splicing where RNA polymerase II (RNAPII) would pass rapidly through the short gene, being all introns incapable to be matured, whereas in long genes, with long introns, spliceosome would have time to remove all introns from the pre-mRNA, This work was supported by the funded project called Epigenética del proceso de transición de epitelio a mesénquima y su reversión (BFU2017-85420-R)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Human prefoldin modulates co-transcriptional pre-mRNA splicing

  • Payán-Bravo, Laura
  • Fontalva, Sara
  • Peñate, Xenia
  • Cases, Ildefonso
  • Guerrero-Martínez, José A.
  • Pareja-Sánchez, Yerma
  • Odriozola-Gil, Yosu
  • Lara, Ester
  • Jimeno-González, Silvia
  • Suñé, Carlos
  • Muñoz-Centeno, Mari Cruz
  • Reyes, José C.
  • Chávez, Sebastián
Prefoldin is a heterohexameric complex conserved from archaea to humans that plays a cochaperone role during the co-translational folding of actin and tubulin monomers. Additional functions of prefoldin have been described, including a positive contribution to transcription elongation and chromatin dynamics in yeast. Here we show that prefoldin perturbations provoked transcriptional alterations across the human genome. Severe pre-mRNA splicing defects were also detected, particularly after serum stimulation. We found impairment of co-transcriptional splicing during transcription elongation, which explains why the induction of long genes with a high number of introns was affected the most. We detected genome-wide prefoldin binding to transcribed genes and found that it correlated with the negative impact of prefoldin depletion on gene expression. Lack of prefoldin caused global decrease in Ser2 and Ser5 phosphorylation of the RNA polymerase II carboxy-terminal domain. It also reduced the recruitment of the CTD kinase CDK9 to transcribed genes, and the association of splicing factors PRP19 and U2AF65 to chromatin, which is known to depend on CTD phosphorylation. Altogether the reported results indicate that human prefoldin is able to act locally on the genome to modulate gene expression by influencing phosphorylation of elongating RNA polymerase II, and thereby regulating co-transcriptional splicing., Ministerio de Ciencia e Innovación-Agencia Estatal de Investigación [BFU2016-77728-C3-1-P to S.C. and BFU2017-85420-R to J.C.R.] co-financed with European Union funds (FEDER); Andalusian Government [P12-BIO1938MO, BIO271, US-1256285 to S.C., BIO321 to J.C.R.]; Junta de Andalucía (to L.P.-B.). Funding for open access charge: Ministerio de Ciencia e Innovación-Agencia Estatal de Investigación [BFU2016-77728-C3-1-P]., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Contribución de congreso (ConferenceOutput)

Regulation of enhancers, co-expression domains and splicing efficiency by TGFß

  • Guerrero-Martínez, José A.
  • Sánchez-Escabias, Elena
  • Gómez-Marín, Elena
  • Basurto-Cayuela, Laura
  • Pozuelo-Sánchez, Isabel
  • Ceballos-Chávez, María
  • Reyes, José C.
Resumen del trabajo presentado en la I Reunión de la Red de Excelencia Temática, celebrada en Sevilla (España), los días 12 y 13 de julio de 2021, TGFβ cytokines have crucial roles in development, proliferation, tissue homeostasis, differentiation and immune regulation. Consequently, alterations in TGFβ signaling underlie numerous diseases, including cancer. TGFβ is one of the most potent inductors of epithelial to mesenchymal transition (EMT) in normal and oncogenic epithelial cells from different origins. EMT and its reversion (MET) are common processes during embryonic development and have attracted considerable interest due to the fact that they seem to be related to tumor cells dissemination and migration, generation of tumor circulating cells, cancer stem cells and metastasis formation. TGFβ causes a large reorganization of gene expression patterns and epigenetic information, that we are only starting to understand. In our group we are investigating how TGFβ causes these reorganization of gene expression patterns. We have cartographied the genomic transcriptional enhancers that are regulated by TGFβ in a breast epithelial cell line. In fact, TGFβ triggers a fast and widespread increase in chromatin accessibility in about 80% of enhancers, irrespective of whether they are activated, repressed or not regulated by TGFβ. We have also shown that most TGFβ-regulated genes are located around enhancers regulated in the same way, often creating domains of several co-regulated genes that we term TGFβ regulatory domains (TRD). We are currently investigating how the 3D organization of the genome connect the enhancers with the TRDs. We have also investigated whether regulation co-transcriptional splicing efficiency at the whole gene level is used to regulate gene expression by TGFβ. First we found that the existence of two well-differentiated strategies for co-transcriptional splicing efficiency, at the extremes of a gradient: short genes, that produces high levels of pre-mRNA display a relatively inefficient splicing while long genes with relatively low pre-mRNA levels present efficient splicing. Furthermore, we found that the TGFβ pathway regulates the general co-transcriptional splicing efficiency causing changes in mature mRNA levels. Taken together, our data indicate that co-transcriptional splicing efficiency is a gene-specific characteristic that can be regulated to control gene expression. Finally, other members of the group are looking for chromatin factors that control gene expression changes caused by TGFβ., This work was funded by the Spanish Ministry of Economy and Competitiveness (BFU2014-53543-P and BFU2017-85420-R), by Junta de Andalucía (P18-FR-1962) and by Fundación Vencer el Cáncer (VEC – 001/2014 FVEC-FPS)
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Co-transcriptional splicing efficiency is a gene-specific feature that can be regulated by TGFβ

  • Sánchez-Escabias, Elena
  • Guerrero-Martínez, José A.
  • Reyes, José C.
Differential splicing efficiency of specific introns is a mechanism that dramatically increases protein diversity, based on selection of alternative exons for the final mature mRNA. However, it is unclear whether splicing efficiency of introns within the same gene is coordinated and eventually regulated as a mechanism to control mature mRNA levels. Based on nascent chromatin-associated RNA-sequencing data, we now find that co-transcriptional splicing (CTS) efficiency tends to be similar between the different introns of a gene. We establish that two well-differentiated strategies for CTS efficiency exist, at the extremes of a gradient: short genes that produce high levels of pre-mRNA undergo inefficient splicing, while long genes with relatively low levels of pre-mRNA have an efficient splicing. Notably, we observe that genes with efficient CTS display a higher level of mature mRNA relative to their pre-mRNA levels. Further, we show that the TGFβ signal transduction pathway regulates the general CTS efficiency, causing changes in mature mRNA levels. Taken together, our data indicate that CTS efficiency is a gene-specific characteristic that can be regulated to control gene expression., This work was funded by the Spanish Ministry of Economy and Competitiveness MCIN/AEI/10.13039/501100011033/ (grant numbers BFU2017-85420-R and PID2020-118516GB-I00), the Junta de Andalucía (grant P18-FR-1962 and BIO-321), “Fundación Vencer El Cancer” (VEC) and the European Union FEDER “A way to build Europe”. CABIMER is a Center partially funded by the Junta de Andalucía.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Human prefoldin modulates co-transcriptional pre-mRNA splicing.

  • Payán-Bravo, Laura
  • Fontalva, Sara
  • Peñate, Xenia
  • Cases, Ildefonso
  • Guerrero-Martínez, José A.
  • Pareja-Sánchez, Yerma
  • Odriozola-Gil, Yosu
  • Lara, Ester
  • Jimeno-González, Silvia
  • Suñé, Carlos
  • Muñoz-Centeno, Mari Cruz
  • Reyes, José C.
  • Chávez, Sebastián
Prefoldin is a heterohexameric complex conserved from archaea to humans that plays a cochaperone role during the co-translational folding of actin and tubulin monomers. Additional functions of prefoldin have been described, including a positive contribution to transcription elongation and chromatin dynamics in yeast. Here we show that prefoldin perturbations provoked transcriptional alterations across the human genome. Severe pre-mRNA splicing defects were also detected, particularly after serum stimulation. We found impairment of co-transcriptional splicing during transcription elongation, which explains why the induction of long genes with a high number of introns was affected the most. We detected genome-wide prefoldin binding to transcribed genes and found that it correlated with the negative impact of prefoldin depletion on gene expression. Lack of prefoldin caused global decrease in Ser2 and Ser5 phosphorylation of the RNA polymerase II carboxy-terminal domain. It also reduced the recruitment of the CTD kinase CDK9 to transcribed genes, and the association of splicing factors PRP19 and U2AF65 to chromatin, which is known to depend on CTD phosphorylation. Altogether the reported results indicate that human prefoldin is able to act locally on the genome to modulate gene expression by influencing phosphorylation of elongating RNA polymerase II, and thereby regulating co-transcriptional splicing., Ministerio de Ciencia e Innovación-Agencia Estatal de Investigación [BFU2016-77728-C3-1-P to S.C. and BFU2017-85420-R to J.C.R.] co-financed with European Union funds (FEDER); Andalusian Government [P12-BIO1938MO, BIO271, US-1256285 to S.C., BIO321 to J.C.R.]; Junta de Andalucía (to L.P.-B.). Funding for open access charge: Ministerio de Ciencia e Innovación-Agencia Estatal de Investigación [BFU2016-77728-C3-1-P].
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

TGFβ promotes widespread enhancer chromatin opening and operates on genomic regulatory domains

  • Guerrero-Martínez, Jose A.
  • Ceballos-Chávez, María
  • Koehler, Florian
  • Peiro Sales, Sandra
  • Reyes, Jose C.
Cromatina; Informàtica del genoma; Transcripció, Cromatina; Informática del genoma; Transcripción, Chromatin; Genome informatics; Transcription, The Transforming Growth Factor-β (TGFβ) signaling pathway controls transcription by regulating enhancer activity. How TGFβ-regulated enhancers are selected and what chromatin changes are associated with TGFβ-dependent enhancers regulation are still unclear. Here we report that TGFβ treatment triggers fast and widespread increase in chromatin accessibility in about 80% of the enhancers of normal mouse mammary epithelial-gland cells, irrespective of whether they are activated, repressed or not regulated by TGFβ. This enhancer opening depends on both the canonical and non-canonical TGFβ pathways. Most TGFβ-regulated genes are located around enhancers regulated in the same way, often creating domains of several co-regulated genes that we term TGFβ regulatory domains (TRD). CRISPR-mediated inactivation of enhancers within TRDs impairs TGFβ-dependent regulation of all co-regulated genes, demonstrating that enhancer targeting is more promiscuous than previously anticipated. The area of TRD influence is restricted by topologically associating domains (TADs) borders, causing a bias towards co-regulation within TADs., This work was funded by the Spanish Ministry of Economy and Competitiveness (BFU2014-53543-P and BFU2017-85420-R to J.C. Reyes), the Junta de Andalucía (BIO-321), “Fundación Vencer El Cancer” (VEC) and the European Union (FEDER). CABIMER is a Center partially funded by the Junta de Andalucía. S.P was supported by the FERO Foundation, La Caixa Foundation (LCF/PR/PR12/51070001) and Cellex Foundation.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

TGFβ promotes widespread enhancer chromatin opening and operates on genomic regulatory domains

  • Guerrero-Martínez, Jose A.
  • Ceballos-Chávez, María
  • Koehler, Florian
  • Peiro Sales, Sandra
  • Reyes, Jose C.
Cromatina; Informàtica del genoma; Transcripció, Cromatina; Informática del genoma; Transcripción, Chromatin; Genome informatics; Transcription, The Transforming Growth Factor-β (TGFβ) signaling pathway controls transcription by regulating enhancer activity. How TGFβ-regulated enhancers are selected and what chromatin changes are associated with TGFβ-dependent enhancers regulation are still unclear. Here we report that TGFβ treatment triggers fast and widespread increase in chromatin accessibility in about 80% of the enhancers of normal mouse mammary epithelial-gland cells, irrespective of whether they are activated, repressed or not regulated by TGFβ. This enhancer opening depends on both the canonical and non-canonical TGFβ pathways. Most TGFβ-regulated genes are located around enhancers regulated in the same way, often creating domains of several co-regulated genes that we term TGFβ regulatory domains (TRD). CRISPR-mediated inactivation of enhancers within TRDs impairs TGFβ-dependent regulation of all co-regulated genes, demonstrating that enhancer targeting is more promiscuous than previously anticipated. The area of TRD influence is restricted by topologically associating domains (TADs) borders, causing a bias towards co-regulation within TADs., This work was funded by the Spanish Ministry of Economy and Competitiveness (BFU2014-53543-P and BFU2017-85420-R to J.C. Reyes), the Junta de Andalucía (BIO-321), “Fundación Vencer El Cancer” (VEC) and the European Union (FEDER). CABIMER is a Center partially funded by the Junta de Andalucía. S.P was supported by the FERO Foundation, La Caixa Foundation (LCF/PR/PR12/51070001) and Cellex Foundation.